Takeda Unit Fights $155M IP Loss, Bayer Wants $27M More
A Takeda Pharmaceutical unit urged a Delaware federal court Friday to throw out a jury's $155 million verdict for infringing Bayer's hemophilia treatment patent, while Bayer asked the judge in a...To view the full article, register now.
Already a subscriber? Click here to view full article